237 related articles for article (PubMed ID: 30088546)
1. Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study.
Goulart LS; Souza WWR; Vieira CA; Lima JS; Olinda RA; Araújo C
Einstein (Sao Paulo); 2018 Aug; 16(3):eAO4224. PubMed ID: 30088546
[TBL] [Abstract][Full Text] [Related]
2. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors.
Paula SB; Morey AT; Santos JP; Santos PM; Gameiro DG; Kerbauy G; Sena EM; Ueda LT; Carneiro M; Pinge-Filho P; Yamauchi LM; Yamada-Ogatta SF
J Infect Dev Ctries; 2015 Dec; 9(12):1350-9. PubMed ID: 26719941
[TBL] [Abstract][Full Text] [Related]
3. Oral Candida isolates among HIV-infected subjects in Nigeria.
Nweze EI; Ogbonnaya UL
J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
[TBL] [Abstract][Full Text] [Related]
4. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
[TBL] [Abstract][Full Text] [Related]
5. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
Yan Z; Young AL; Hua H; Xu Y
J Rheumatol; 2011 Nov; 38(11):2428-31. PubMed ID: 21844143
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China.
Li YY; Chen WY; Li X; Li HB; Li HQ; Wang L; He L; Yang XP; Wang XC; Huang YL; Yao YG
BMC Infect Dis; 2013 Jan; 13():46. PubMed ID: 23356471
[TBL] [Abstract][Full Text] [Related]
7. Drug-resistant oral candidiasis in patients with HIV infection: a systematic review and meta-analysis.
Keyvanfar A; Najafiarab H; Talebian N; Tafti MF; Adeli G; Ghasemi Z; Tehrani S
BMC Infect Dis; 2024 May; 24(1):546. PubMed ID: 38822256
[TBL] [Abstract][Full Text] [Related]
8. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
9. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Brazilian study of oral Candida species isolated from AIDS patients.
Sant'Ana Pde L; Milan EP; Martinez R; Queiroz-Telles F; Ferreira MS; Alcântara AP; Carvalho MT; Colombo AL
Mem Inst Oswaldo Cruz; 2002 Mar; 97(2):253-7. PubMed ID: 12016452
[TBL] [Abstract][Full Text] [Related]
11. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon.
Ambe NF; Longdoh NA; Tebid P; Bobga TP; Nkfusai CN; Ngwa SB; Nsai FS; Cumber SN
Pan Afr Med J; 2020; 36():23. PubMed ID: 32774600
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and antifungal susceptibility of yeasts obtained from the oral cavity of elderly individuals.
de Resende MA; de Sousa LV; de Oliveira RC; Koga-Ito CY; Lyon JP
Mycopathologia; 2006 Jul; 162(1):39-44. PubMed ID: 16830190
[TBL] [Abstract][Full Text] [Related]
13. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
Zhao M; Zhou ZT
Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratorial features of oral candidiasis in HIV-positive patients.
Spalanzani RN; Mattos K; Marques LI; Barros PFD; Pereira PIP; Paniago AMM; Mendes RP; Chang MR
Rev Soc Bras Med Trop; 2018; 51(3):352-356. PubMed ID: 29972567
[TBL] [Abstract][Full Text] [Related]
15. Candida fermentati from HIV patients in Chennai, South India.
Umamaheswari K; Menon T
Int J Infect Dis; 2008 Nov; 12(6):e153-4. PubMed ID: 18650108
[No Abstract] [Full Text] [Related]
16. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
Costa CR; de Lemos JA; Passos XS; de Araújo CR; Cohen AJ; Souza LK; Silva Mdo R
Mycopathologia; 2006 Jul; 162(1):45-50. PubMed ID: 16830191
[TBL] [Abstract][Full Text] [Related]
17. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
[TBL] [Abstract][Full Text] [Related]
18. Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization.
Delgado AC; de Jesus Pedro R; Aoki FH; Resende MR; Trabasso P; Colombo AL; de Oliveira MS; Mikami Y; Moretti ML
Clin Microbiol Infect; 2009 Apr; 15(4):364-71. PubMed ID: 19431223
[TBL] [Abstract][Full Text] [Related]
19. Azole susceptibility and resistance in Candida isolates from oral candidiasis and oral colonization in HIV positive patients.
Maurya V; Srivastava A; Mishra J; Venkatesh V
J Commun Dis; 2011 Dec; 43(4):269-72. PubMed ID: 23781644
[No Abstract] [Full Text] [Related]
20. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.
Menon T; Umamaheswari K; Kumarasamy N; Solomon S; Thyagarajan SP
Acta Trop; 2001 Oct; 80(2):151-4. PubMed ID: 11600094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
